# Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects

> **NCT02254057** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 47 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BIBT 986 BS - single rising dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02254057
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2002-10
- **Final completion:** —
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02254057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02254057, "Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02254057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*